Atlas Trials

Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Clinical trial NCT02246764 · COMPLETED

Trial details

NCT number
NCT02246764
Sponsor
Aerie Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ocular HypertensionGlaucoma
Start date
2014-09-01
Primary completion
2016-12-01
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.